Delivery Order V797D70258-75A50325F80025
- This federal contract award, valued at $4,142,331.36, was issued by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Heyltex Corporation, a for-profit manufacturer of goods. The award provides funding for Heyltex to purchase Prussian Blue (Radiogardase), an insoluble capsule in a 500mg oral dosage, to support emergency response needs. The contract is a delivery order placed under Heyltex's existing General Services Administration...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,356.63 for Cyanokit 5 gram vials, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Cyanokit is a critical antidote medication used to treat cyanide poisoning and represents part of the federal government's medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,947.02 to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials. This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $43,542,735.04 firm fixed price contract to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer, to provide the medical countermeasure eltrombopag to mitigate thrombocytopenia (low platelet count) following myelosuppressive doses of radiation. The contract has a completion date of June 30, 2024 and was awarded on September 14, 2017. Novartis, which does...
- This federal contract award, valued at $100,000.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Anbex Inc., a for-profit Subchapter S Corporation based in Utah and Virginia. The contract is for the delivery of 130mg potassium iodide tablets, which are critical medical countermeasures used to protect the thyroid gland during radiation emergencies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Anbex holds with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials, with a ceiling value of $13,909.74 under a firm fixed-price contract structure. The award was made on August 8, 2025, with an ultimate completion date of August 11, 2025. No set-aside designation was used for this competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order for Cyanokit 5 gram vials valued at $3,548.60. This firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of October 1, 2025, and was issued without a set-aside designation. The contract represents a specific product requisition under DMS Pharmaceutical Group's larger Indefinite...
- This is a firm fixed price purchase order contract awarded by the Department of Defense Medical Command (MEDCOM) to Pharmalucence, Inc., a specialty pharmaceutical company, for the delivery of sulfur colloid kits. The contract has a ceiling value of $90,265.00 and a period of performance ending on September 30, 2016. Pharmalucence, Inc. has been awarded multiple federal contracts by the Department of Defense and its Defense Health Agency (DHA) component to supply radiopharmaceuticals and related...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Praziquantel 600 mg tablets on September 9, 2025. This firm fixed-price delivery order, valued at $2,771.45, has an ultimate completion date of September 10, 2025, and represents a non-competitive award under an existing contract vehicle. The award will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,643.12 to AmerisourceBergen Drug Corp for the supply of Cyanokit 5 gram vials. This non-competitive, firm fixed-price delivery order was executed on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70258Federal Supply Schedule
- V797D70258-75A50325F80025Delivery Order
The U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a delivery order to Heyltex Corporation for Prussian Blue (Radiogardase) insoluble capsules, 500mg, with a ceiling value of $16.2 million. The contract, awarded on September 30, 2025, is issued under Heyltex's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) and carries a firm fixed price structure with no set-aside designation. Performance will be conducted in Katy, Texas, with an ultimate completion date of September 29, 2027. Prussian Blue is a medical countermeasure used to treat internal contamination from radioactive materials and represents a critical component of the nation's emergency preparedness infrastructure. Heyltex Corporation, a small business manufacturer registered in SAM.gov since 2004, has established itself as a primary federal supplier of this specialized pharmaceutical. The company's consistent selection for large-scale stockpile orders reflects its role in supporting ASPR's mission to enhance national preparedness and response capabilities for radiological emergencies. This contract aligns with broader federal initiatives to maintain adequate supplies of medical countermeasures for potential incidents affecting military personnel, veterans, and civilian populations, demonstrating ongoing government investment in radiation emergency response infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1m | 9/27/25 |